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ABSTRACT 
Background and Objectives: Information about disease incidence is indispensable for the active prevention and 
control of acute myocardial infarction (AMI). The purpose of this study was to provide basic information for the 
establishment of policy related to AMI by examining the long-term trends in incidence of AMI. Subjects and 
Methods: This study identified the trend in disease incidence during between 1997 and 2007 using the Korean 
National Health Insurance Database that includes AMI {the 10th International Classification of Disease (ICD-
10) code: I21, I22, I23, I250, I251} as a primary or secondary disease. Results: The attack and incidence rates 
for AMI in 2007 were 118.4 and 91.8 per 100,000 persons, respectively, and the rates more than doubled for the 
11 years. Both rates were higher among males than females and increased more in the older age groups. Incid-
ence cases accounted for most of the total attack cases every year; however, in recent years the proportion of re-
lapse cases was on the rise. The case fatality rate was highest (14.5%) in 2000, and declined rapidly to 9.8% in 2007. 
The case fatality rate was higher among females than males and the older age groups; in particular, female patients 
≥65 years of age had the highest fatality rate. Conclusion: This study showed that AMI has been on the rise in 
Korea for 11 years. Therefore, the establishment of policy for intensive control of the incidence of AMI is necessary 
by building a continuous monitoring and surveillance system. (Korean Circ J 2009;39:467-476) 
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Introduction 
 
Acute myocardial infarction (AMI) is a disease with 
a high case fatality rate. However, appropriate medical 
services have been reported to reduce mortality and dis-
ability caused by AMI. Currently, AMI is selected as a 
disease for evaluation and monitoring in many coun-
tries, including the United States (US), the European 
countries, as well as Korea.
1-4) 
Although the incidence of AMI in Korea is expected 
to increase rapidly due to westernization of diet and ag-
ing of the population, the exact prevalence and long-
term trends of the disease have not been examined. A 
national sample survey {National Health and Nutrition 
Survey (NHNS)} exists, but statistical accuracy and valid-
ity of the data obtained through such a survey are weak 
and many studies, except NHNS, still examine subjects 
of small, specific areas or some medical institutions with 
the corresponding limitations in representation and 
generalization which are needed for national data.
5)6) 
Therefore, this study determined the long-term inci-
dence and trends of AMI with national health insurance 
claims data between 1997 and 2007 to provide necessary 
data for establishing policies for active prevention and 
management. 
 
Subjects and Methods 
 
Data source and study population 
This study investigated all national health insurance 
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claims due to AMI as a primary and secondary disease 
for the 11 years from 1997 to 2007. To evaluate all AMI 
patients, I21, I22, I23, I250 and I251 of the 10th Inter-
national Classification of Disease (ICD-10) were design-
ated as standards for the disease. 
In 298 classifications of disease of the Korean Stand-
ard Classification of Disease and Cause of Death, AMI 
is the 147th disease and includes I21 and I22 of ICD-10. 
However, as some hospitals used I250 and I251 to re-
quest health insurance for percutaneous coronary in-
tervention (PCI) or coronary artery bypass graft (CABG) 
surgery conducted for AMI patients, this study reflected 
maximum results of previous studies showing high treat-
ment and examination rates of AMI patients {CABG, 
percutaneous transluminal coronary angioplasty (PTCA), 
troponin, or creatine kinase} and a high true positive 
rate of AMI in I23, I250, and I251 to select diagnosis 
codes for analysis.
5) 
 
Statistical analysis 
 
Building episode of care 
In the Monitoring of Trends and Determinants in 
Cardiovascular Disease (MONICA) project another in-
cident case of AMI at the same site within 28 days from 
the first incident case is considered an episode of AMI 
care.
2) This study also treated a case claiming health in-
surance with the same disease within 28 days from the 
first request for AMI as an episode and recorded epi-
sodes by year from 1997 to 2007.
5) When a claim was 
filed with health insurance for an AMI at the end of a 
year and then a claim was filed again within 28 days in 
Table 1. Attack rate of acute myocardial infarction by age or gender: 1997-2007
  Year 
  1997  1998  1999  2000  2001  2002  2003  2004  2005  2006  2007 
T o t a l             
Population* 45,953,580  46,286,503  46,616,677  47,008,111 47,357,362 47,622,179 47,859,311 48,039,415 48,138,077  48,297,184 48,456,369
Attack  case 22,039 24,912 30,365 31,996 39,201 45,625 48,895 52,331 54,410 55,261 57,350 
Attack rate
†  48.0  53.8  65.1  68.1  82.8  95.8 102.2 108.9 113.0 114.4 118.4 
Gender   
Male   
Population*  23,148,092 23,295,727 23,457,837 23,666,769 23,843,136 23,970,035 24,089,703 24,165,488 24,190,906 24,267,609 24,344,276
Attack  case 13,320 14,825 17,828 18,646 23,016 26,829 29,144 31,022 32,414 33,481 34,713 
Attack rate
†  57.5 63.6 76.0 78.8 96.5 111.9  121.0  128.4  134.0  138.0  142.6 
Female   
Population* 22,805,488  22,990,776  23,158,840  23,341,342 23,514,226 23,652,144 23,769,608 23,873,927 23,947,171  24,029,575 24,112,093
Attack  case  8,719  10,087 12,537 13,350 16,185 18,796 19,751 21,309 21,996 21,780 22,637 
Attack rate
†  38.2 43.9 54.1 57.2 68.8 79.5 83.1 89.3 91.9 90.6 93.9 
Age   
0-44   
Population* 34,696,864  34,676,955  34,610,580  34,502,465 34,326,287 34,047,914 33,706,685 33,273,360 32,747,120 32,254,176 31,775,248
Attack  case 2,423 2,532 2,830 3,092 3,743 4,077 4,079 3,894 3,781 3,768 3,671 
Attack rate
†  7.0  7.3  8.2  9.0 10.9 12.0 12.1 11.7 11.5 11.7 11.6 
45-54   
Population* 4,656,982  4,787,167 4,986,346  5,287,305 5,583,838 5,852,764 6,144,056 6,474,983 6,828,251  7,189,002 7,504,276
Attack case  3,651  3,770  4,659  4,983  6,137 7,208 7,767 8,145 8,529 8,987 9,112 
Attack rate
†  78.4  78.8  93.4  94.2  109.9 123.2 126.4 125.8 124.9 125.0 121.4 
55-64             
Population*  3,670,423 3,753,328 3,796,175 3,823,445 3,868,867 3,949,426 4,040,452 4,125,098 4,196,064 4,268,304 4,366,482
Attack case  6,529  7,284  8,677  8,624 10,321 11,893 12,564 13,177 13,362 12,949 12,911 
Attack rate
†  177.9 194.1 228.6 225.6 266.8 301.1 311.0 319.4 318.4 303.4 295.7 
65-79             
Population*  2,487,806 2,612,914 2,755,750 2,911,509 3,065,733 3,223,033 3,377,469 3,530,032 3,690,418 3,863,541 4,038,285
Attack case  7,910  9,384  11,720 12,384 15,425 18,048 19,607 21,630 22,784 23,221 24,678 
Attack rate
†  318.0 359.1 425.3 425.3 503.1 560.0 580.5 612.7 617.4 601.0 611.1 
80+             
Population*  441,505 456,139 467,826 483,387 512,637 549,042 590,649 635,942 676,224 722,161 772,078
Attack case  1,526 1,942 2,479 2,913 3,575 4,399 4,878 5,485 5,954 6,336 6,978 
Attack rate
†  345.6 425.7 529.9 602.6 697.4 801.2 825.9 862.5 880.5 877.4 903.8 
*Mid-year population,  †Attack rate=Attract case/Mid-year population×100,000 (per 100,000)    
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the next year, the episode was included in the year of 
the first incident case. For example, if patient A expe-
rienced an episode on 15 December 1997 and had an-
other episode on 5 January 1998, the latter episode was 
bound to the episode of 15 December 1997 and in-
cluded in the incident cases of 1997. 
 
Measuring disease incidence 
The scale of the disease incidence for 11 years was ex-
amined by separation into attack, incidence, relapse, and 
case fatality rates, and the scale of disease incidence ac-
cording to gender and age was also investigated. Age was 
classified into five groups (0-44, 45-54, 55-64, 65-79, 
and  ≥80) and the ages of patients in each year were also 
calculated.
5) 
The attack rate was calculated by dividing the num-
ber of total episodes (total attacks) by the population 
number at mid-year and the same patients could pro-
duce several attacks. The incidence and relapse rates 
were made by dividing the number of patients with first 
attacks throughout their entire lives by the population 
number at mid-year every year and dividing the number 
of total attacks less the number of first attacks of patients 
by the population number at mid-year, respectively. The 
case fatality rate was defined as the number of deaths due 
to the disease within 28 days after the attack according 
to the MONICA project.
2) The attack and incidence fa-
tality rates were calculated by dividing the number of 
deaths within 28 days by the number of total attacks and 
by the number of the first attacks of patients throughout 
Table 2. Incidence rate of acute myocardial infarction by age or gender: 1997-2007
Year 
 
1997  1998  1999  2000  2001  2002  2003  2004  2005  2006  2007 
T o t a l              
Population* 45,953,580  46,286,503  46,616,677  47,008,111 47,357,362 47,622,179 47,859,311 48,039,415 48,138,077 48,297,184 48,456,369
Incident  case 19,986 22,156 26,645 27,762 33,539 38,061 40,106 41,361 42,702 42,411 44,460
Incidence rate
† 43.5  47.9  57.2  59.1  70.8  79.9  83.8  86.1  88.7  87.8  91.8 
Gender        
Male        
Population* 23,148,092  23,295,727  23,457,837  23,666,769 23,843,136 23,970,035 24,089,703 24,165,488 24,190,906 24,267,609 24,344,276
Incident  case 11,948 12,996 15,392 15,918 19,308 21,934 23,317 23,912 24,917 25,225 26,365
Incidence rate
† 51.6  55.8  65.6  67.3  81.0  91.5  96.8  99.0  103.0  103.9  108.3 
F e m a l e              
Population* 22,805,488  22,990,776  23,158,840  23,341,342 23,514,226 23,652,144 23,769,608 23,873,927 23,947,171 24,029,575 24,112,093
Incident  case  8,038  9,160  11,253 11,844 14,231 16,127 16,789 17,449 17,785 17,186 18,095 
Incidence rate
†  35.2 39.8 48.6 50.7 60.5 68.2 70.6 73.1 74.3 71.5 75.0 
Age        
0-44        
Population* 34,696,864  34,676,955  34,610,580  34,502,465 34,326,287 34,047,914 33,706,685 33,273,360 32,747,120 32,254,176 31,775,248
Incident  case 2,280 2,328 2,596 2,848 3,415 3,671 3,648 3,375 3,240 3,249 3,122 
Incidence rate
† 6.6  6.7  7.5  8.3  9.9  10.8  10.8  10.1  9.9  10.1  9.8 
45-5 4              
Population*  4,656,982 4,787,167 4,986,346 5,287,305 5,583,838 5,852,764 6,144,056 6,474,983 6,828,251 7,189,002 7,504,276
Incident case  3,272  3,313  4,117  4,327 5,246 6,087 6,415 6,488 6,787 7,093 7,220 
Incidence rate
†  70.3 69.2 82.6 81.8 93.9  104.0  104.4  100.2  99.4 98.7 96.2 
55-6 4              
Population* 3,670,423  3,753,328  3,796,175  3,823,445 3,868,867 3,949,426 4,040,452 4,125,098 4,196,064 4,268,304 4,366,482
Incident  case 5,856 6,435 7,434 7,361 8,633 9,728 10,118 10,196  10,327 9,787 9,990 
Incidence rate
†  159.5 171.4 195.8 192.5 223.1 246.3 250.4 247.2 246.1 229.3 228.8 
65-7 9              
Population* 2,487,806  2,612,914  2,755,750  2,911,509 3,065,733 3,223,033 3,377,469 3,530,032 3,690,418 3,863,541 4,038,285
Incident  case  7,148  8,275  10,247 10,607 13,071 14,776 15,762 16,784 17,506 17,242 18,572 
Incidence rate
†  287.3 316.7 371.8 364.3 426.4 458.5 466.7 475.5 474.4 446.3 459.9 
8 0 +              
Population* 441,505  456,139  467,826  483,387 512,637 549,042 590,649 635,942 676,224  722,161 772,078
Incident case  1,430  1,805  2,251  2,619  3,174 3,799 4,163 4,518 4,842 5,040 5,556 
Incidence rate
†  323.9 395.7 481.2 541.8 619.2 691.9 704.8 710.4 716.0 697.9 719.6 
*Mid-year population,  †Incidence rate=Incident case/Mid-year population×100,000 (per 100,000) 
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their entire lives each year, respectively. The population 
number at mid-year was the total population number 
on 1 July each year and was obtained from the data of 
the Korea National Statistical Office.
7) 
This study evaluated the attack, incidence, and case 
fatality rates according to years and examined the long-
term trends of the disease incidence. By considering char-
acteristics of population structure each year, age-stand-
ardization was performed. The standardized population 
for age-standardization was calculated by adding the po-
pulation numbers from 1997 to 2007 according to age 
groups (0-44, 45-54, 55-64, 65-79, and  ≥80) each year. 
 
Results 
 
When the number of attacks and the attack rate for 
AMIs were investigated according to year, there was an 
increase by 2.6 times from 22,039 cases in 1997 to 57,350 
in 2007 and by approximately 2.5 times from 48.0 cases 
per 100,000 persons in 1997 to 118.4 cases per 100,000 
persons in 2007, respectively (Table 1). The incident cases 
(the number of first AMI attacks of patients throughout 
their entire lives) increased by 2.2 times from 19,986 
cases in 1997 to 44,460 cases in 2007, and the incidence 
increased by 2.1 times from 43.5 cases per 100,000 per-
sons in 1997 to 91.8 cases per 100,000 persons in 2007 
(Table 2). 
In comparing the attack rate and incidence for each 
year according to gender and age, males showed higher 
rates than females and both of the rates became higher 
with older ages (Tables 1 and 2). 
Both the attack rate and incidence increased rapidly 
from 1997 to 2002 and showed a continuous increase 
after 2002. This tendency was similar when the rates were 
analyzed according to gender and age (Fig. 1). When age-
standardized attack rates and incidences were compared 
according to year, there was also a sharp increase to 2002 
and the increasing tendency slowed after 2002. This ten-
Fig. 1. Crude or age-standardized attack and incidence rates of acute myocardial infarction by gender: 1997-2007.
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dency was the same even after males and females were 
separated (Fig. 1). 
Although incident cases, the first attacks of AMI th-
roughout the entire life, accounted for most of the total 
attacks each year, the percentage of relapse cases has cur-
rently increased. While the increase in the incidence has 
slowed since 2002, the relapse rates have tended to in-
crease continuously (Fig. 2). The incidence increased 
from 79.9 cases per 100,000 persons in 2002 to 91.8 
cases per 100,000 persons in 2007 (approximately 15%) 
and the relapse rates increased dramatically from 15.9 
to 26.6 (approximately 67%). This tendency was similar 
even after age-standardization. The attack fatality rates 
had increased from 13.3% in 1997 to 14.5% in 2000 and 
then declined continuously. The attack fatality rate de-
creased sharply in 2007 to 9.8% (Table 3). The incidence 
fatality rate also increased from 14.1% in 1997 to 15.4% 
in 2000 and then decreased slowly. The incidence fa-
tality rate of 2007 also decreased to 10.8% (Table 4). 
When the attack and incidence fatality rates were com-
pared according to gender and age, the rates of females 
were higher than males and ≥80 and the 65-79 year age 
groups had higher attack and incidence fatality rates 
(Tables 3 and 4). Currently, the case fatality rates have 
decreased continuously and this tendency was similar 
after age-standardization (Fig. 3). In comparing the in-
cidence and incidence fatality rates of males and fe-
males according to age groups (<65 and ≥65) each year 
(Fig. 4), the incidence rates of males were higher than 
females in both of the groups of (<65 years and ≥65 
years) for 11 years. However, while the incidence fatali-
ty rates were higher in males than in females for the 
<65 year age group, the rates of females were higher than 
males for the ≥65 year age group. This tendency was si-
milar in comparison to the attack and attack fatality rates. 
 
Discussion 
 
This study revealed that the attack and incidence ra-
tes for AMI have increased continuously in Korea for 
the last 11 years. The attack and incidence rates increas-
ed by around 10% each year and the increasing tendency 
of the two rates was the greatest from 2000 to 2002. 
The increase in attack and incidence rates can be at-
tributed to an aging population. In a country experi-
encing a rapidly aging population, such as Korea, the 
larger number of elderly is expected to lead to a natural 
increase in chronic diseases, such as AMI.
5) The per-
centage of the population ≥65 years of age among the 
total population increased continuously from 6.4% in 
1997 to 9.9% in 2007.
7) 
When the age-standardized attack and incidence ra-
tes for each year were examined in this study, the increase 
in the attack and incidence rates currently slowed. This 
finding supports the suggestion that the increasing ten-
dency for AMIs in Korea follows the increase in the eld-
erly with high attack rate and incidence rates. A previous 
international study also reported similar results.
8) 
A second reason for the increase in attack and incid-
ence rates is the development of technologies for diag-
nosis. Recently, cardiac-specific troponins have been re-
cognized as the most favorable biochemical myocardial 
index for evaluation of patients with acute coronary syn-
drome because of various properties.
9) This development 
in new technologies for diagnosis is expected to increase 
the diagnosis of AMIs. In early 2002, when the troponin 
test was actively introduced, both the attack and incid-
ence rates increased dramatically.   
According to a 10-year survey of MONICA following 
up incidences, deaths, and risk factors for AMI in sub-
jects 35-64 years of age in 21 countries, including west 
European countries, China, and Japan, the incidence of 
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males was the highest in Finland (915 per 100,000 per-
sons) and the rate of females was the highest in Eng-
land (256 per 100,000 persons).
2) Although this study 
was conducted at a different time compared to the sur-
vey, the incidence rates of AMIs in Korea in 1997 in the 
current study (51.6 per 100,000 persons for males and 
35.2 per 100,000 persons for females) were lower than 
the corresponding rates in west European countries by 
as much as 17 and 7 times, respectively, as well as China 
(76 per 100,000 persons). Lundblad et al.
10) reported 
that the incidence rates of males and females of Sweden 
in 2004 were 300 and 100 per 100,000 persons, respec-
tively, which were higher than the incidence rates in the 
current study (males, 99.0 per 100,000 persons; and fe-
males, 73.1 per 100,000 persons) determined in a sim-
ilar year. 
However, because each country has a different system 
to monitor disease and because this study investigated 
only AMI patients visiting medical institutions, it is hard 
to compare the results of the countries directly. Consi-
dering that the previous study populations were west 
European countries and Japan with a large elderly pop-
ulation and that aging of the population is thought to 
be one of the reasons for the increasing tendency of 
AMIs in Korea, the risk of myocardial infarction attacks 
and incidence in Korea is assumed to continue to in-
crease.  
When AMI attack and incidence rates were exam-
ined according to the age groups each year, the rates grew 
up suddenly after 45 years of age and the increasing ten-
Table 3. Attack fatality rate of acute myocardial infarction by age or gender: 1997-2007
Year 
 
1997  1998  1999  2000  2001  2002  2003  2004  2005  2006  2007
T o t a l              
Attack case  22,039  24,912  30,365  31,996  39,201 45,625 48,895 52,331 54,410  55,261  57,350
Case  fatality  2,938 3,530 4,328 4,652 5,120 5,902 5,815 6,151 6,424  6,236  5,598
Attack  fatality  rate*  13.3 14.2 14.3 14.5 13.1 12.9 11.9 11.8 11.8  11.3  9.8
G e n d e r                
M a l e                
Attack case  13,320  14,825  17,828  18,646 23,016  26,829 29,144  31,022  32,414  33,481  34,713
Case fatality  1,669  1,937  2,417  2,511  2,785 3,219 3,164 3,297 3,488  3,394  3,022
Attack  fatality  rate*  12.5 13.1 13.6 13.5 12.1 12.0 10.9 10.6 10.8  10.1  8.7
F e m a l e                
Attack case  8,719  10,087  12,537  13,350 16,185 18,796 19,751 21,309 21,996 21,780  22,637
Case fatality  1,269  1,593  1,911  2,141  2,335 2,683 2,651 2,854 2,936  2,842  2,576
Attack  fatality  rate*  14.6 15.8 15.2 16.0 14.4 14.3 13.4 13.4 13.3  13.0  11.4
A g e                
0-4 4                
Attack  case  2,423 2,532 2,830 3,092 3,743 4,077 4,079 3,894 3,781  3,768  3,671
Case  fatality  198 250 249 280 313 350 336 297 307  294  240
Attack fatality rate*  8.2  9.9  8.8 9.1 8.4 8.6 8.2 7.6 8.1  7.8  6.5
45-5 4                
Attack case  3,651  3,770  4,659  4,983  6,137 7,208 7,767 8,145 8,529  8,987  9,112
Case  fatality  292 298 411 435 438 497 496 547 536  518  441
Attack fatality rate*  8.0  7.9  8.8 8.7 7.1 6.9 6.4 6.7 6.3  5.8  4.8
55-6 4                
Attack case  6,529  7,284  8,677  8,624  10,321  11,893  12,564 13,177  13,362  12,949  12,911
Case  fatality  654 742 880 861 901  1,008  927 925 916  841  701
Attack  fatality  rate*  10.0  10.2  10.1  10.0  8.7 8.5 7.4 7.0 6.9  6.5  5.4
65-7 9                
Attack case  7,910  9,384  11,720  12,384 15,425 18,048 19,607 21,630  22,784  23,221  24,678
Case fatality  1,338  1,598  2,014  2,150  2,377 2,710 2,656 2,798 2,913  2,763  2,545
Attack fatality rate*  16.9  17.0  17.2  17.4 15.4 15.0 13.5 12.9 12.8  11.9  10.3
80+               
Attack case  1,526  1,942  2,479  2,913  3,575 4,399 4,878 5,485 5,954  6,336  6,978
Case  fatality  456  642  774  926  1,091 1,337 1,400 1,584 1,752  1,820  1,671
Attack  fatality  rate*  29.9 33.1 31.2 31.8 30.5 30.4 28.7 28.9 29.4  28.7  23.9
*Attack fatality rate=Case fatality/Attack case×100 (%) 
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dency was the highest, especially after 65 years of age. 
The reasons for the higher attack and incidence rates 
after 45 years of age were reported to be related to smok-
ing and stress for males and with changes in hormones 
associated with menopause in females.
8)11-15) 
In this study, both the attack and incidence fatality 
rates have fallen considerably since 2000. The study of 
Lundblad et al.
10) in which changes in the incidence fa-
tality rates of AMIs in Sweden were surveyed for 20 years 
also revealed that the incidence fatality rate was reduced 
sharply from 50% in 1985 to 30% in 2004. Wellenius 
and Mittleman
16) investigated changes in the attack fa-
tality rate with beneficiaries of medicare in the US for 
20 years and found that the attack fatality rate declin-
ed from 25.3% in 1984 to 17.2% in 2003. The decre-
ase in the fatality rate was reported to result from the 
development of treatments, such as thrombolytic therapy 
and early visits to hospitals by patients.
1)17-21) 
The fatality rates of this study were lower than those 
of other countries. While the MONICA study reported 
that the attack fatality rate of males and females in 1994 
were 49% and 54% respectively,
2) the current study found 
that the rates in 1997 were 12.5% and 14.6% respectively. 
Although the two studies were performed at different 
times, the results of the current study revealed lower fa-
tality rates. The latest study by Lundblad et al.
10) also 
reported that the incidence fatality rate in Sweden in 
2004 was 30% and the rate was higher than that of Ko-
Table 4. Incidence fatality rate of acute myocardial infarction by age or gender: 1997-2007
  Year 
  1997  1998  1999  2000  2001  2002  2003  2004  2005  2006  2007
T o t a l              
Incidence case  19,986  22,156  26,645 27,762 33,539 38,061 40,106 41,361 42,702  42,411  44,460
Case fatality  2,814  3,316  4,053  4,289  4,678 5,318 5,207 5,395 5,618  5,403  4,819
Incidence  fatality  rate*  14.1 15.0 15.2 15.4 13.9 14.0 13.0 13.0 13.2  12.7  10.8
G e n d e r                
M a l e                
Incidence case  11,948  12,996  15,392 15,918 19,308 21,934 23,317 23,912  24,917  25,225  26,365
Case fatality  1,596  1,817  2,260  2,281  2,514 2,859 2,799 2,879 3,002  2,913  2,569
Incidence  fatality  rate*  13.4 14.0 14.7 14.3 13.0 13.0 12.0 12.0 12.0  11.5 9.7
F e m a l e                
Incidence case  8,038  9,160  11,253 11,844 14,231 16,127 16,789 17,449  17,785  17,186  18,095
Case fatality  1,218  1,499  1,793  2,008  2,164 2,459 2,408 2,516 2,616  2,490  2,250
Incidence  fatality  rate*  15.2 16.4 15.9 17.0 15.2 15.2 14.3 14.4 14.7  14.5  12.4
A g e                
0-4 4                
Incidence  case  2,280 2,328 2,596 2,848 3,415 3,671 3,648 3,375 3,240  3,249  3,122
Case  fatality  192 242 246 277 303 332 325 286 288  283  229
Incidence fatality rate*  8.4  10.4  9.5 9.7 8.9 9.0 8.9 8.5 8.9  8.7  7.3
45-5 4                
Incidence case  3,272  3,313  4,117  4,327 5,246 6,087 6,415 6,488 6,787  7,093  7,220
Case  fatality  281 283 391 411 409 462 456 510 478  470  399
Incidence  fatality  rate*  8.6 8.5 9.5 9.5 7.8 7.6 7.1 7.9 7.0  6.6  5.5
55-6 4                
Incidence case  5,856  6,435  7,434 7,361 8,633 9,728 10,118  10,196  10,327  9,787  9,990
Case  fatality  621 701 826 777 820 914 827 801 809  722  604
Incidence fatality rate*  10.6  10.9  11.1  10.6  9.5 9.4 8.2 7.9 7.8  7.4  6.0
65-7 9                
Incidence case  7,148  8,275  10,247  10,607 13,071 14,776 15,762 16,784  17,506  17,242  18,572
Case fatality  1,278  1,483  1,868  1,945  2,149  2,395  2,322  2,379  2,495  2,350  2,147
Incidence  fatality  rate*  17.9 17.9 18.2 18.3 16.4 16.2 14.7 14.2 14.3  13.6  11.6
80+               
Incidence case  1,430  1,805  2,251  2,619  3,174 3,799 4,163 4,518 4,842  5,040  5,556
Case  fatality  442 607 722 879 997  1,215  1,277  1,419  1,548  1,578  1,440
Incidence  fatality  rate*  30.9 33.6 32.1 33.6 31.4 32.0 30.7 31.4 32.0  31.3  25.9
*Incidence fatality rate=Case fatality/Incidence case×100 (%) 
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rea in the same year (13.0%). The study performed with 
beneficiaries of medicare in the US reported that the at-
tack fatality rate in 2003 was 17.2% and the rate was high-
er than the current study in the same year (11.9%).
16) 
When the fatality rates were compared according to 
age and gender, the rate was higher with older age and 
the fatality rate of females was higher than that of males. 
Many previous studies reported same results and sug-
gested that the higher fatality rate of persons with older 
ages was led to by higher frequencies of congestive heart 
failure, arrhythmia, atrioventricular block, reinfarction 
and multivessel disease and lower frequencies of β-
blocker, heparin, thrombolytic therapy and coronary 
angiography and angioplasty.
1)22-24) In addition, the rea-
sons for a higher fatality rate in females compared to 
the rate in males were reported to be a larger composi-
tion of the elderly among females, higher frequencies of 
hypertension, diabetes, and heart failure, a higher fre-
quency of left ventricular failure during hospitalization, 
andlower frequencies of thrombolytic therapy, coronary 
angiography, and angioplasty.
1)25-27) The current study 
also revealed a higher fatality rate in females of older 
ages. In comparing the fatality rates of males and females 
after dividing the ages into <65 and ≥65, while males 
had a higher fatality rate than females in the group <65 
years of age, females had a higher fatality rate in the 
group  ≥65 years of age for 11 years. In females, the per-
centage of case fatalities  ≥65 years of age among the to-
tal case fatalities for 11 years averaged 82.1% (range, 
76.4-87.8% by year) and it was considerably higher than 
males (57.3%; range, 49.4-64.7%). Thus, deaths of fe-
males  ≥65 years of age exceeded the deaths of males. 
Fig. 3. Crude or age-standardized attack and incidence fatality rates of acute myocardial infarction by gender: 1997-2007.
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One of the reasons for this finding is a tendency that 
middle-aged females in Korea respond to health prob-
lems less actively by themselves compared to males.
11) 
To verify this finding, more in-depth research will be 
necessary. 
Based on the collective results of this study, AMI at-
tack and incidence rates of Korea tended to increase 
overall for the 11 years. In particular, as the relapse rates 
grew sharply, policies, including continuous monitoring 
to prevent relapse after optimal treatments and estab-
lishment of surveillance system, are desperately needed. 
In addition, females showed relatively lower attack and 
incidence rates, but higher fatality rates than males, so 
more intensive management for females, especially ≥65 
years of age, is necessary. 
One of the limitations of this study was that it used 
national health insurance claims data for 11 years to de-
termine the scale of the incidence of AMIs. That could 
exclude AMI deaths not receiving medical services and 
inadequately investigate the incidence scale accurately 
because of the lack of validity of diagnosis in the data. 
Therefore, due to exclusion of AMI patients without 
symptoms and an incorrect diagnosis, the incidence scale 
could be underestimated or overestimated.
28)29) Accord-
ing to the study by Kim
5) determining the validity of 
diagnosis by investigating the medical records of pa-
tients diagnosed with an AMI with national health in-
surance claims data, 1,573 among the total number of 
subjects (2,008) were actual AMI patients for an 80% rate. 
To determine a more accurate incidence scale, measures 
to increase the validity of diagnosis with the data and 
development of models for diagnosis are needed. 
Fig. 4. Incidence and incidence fatality rates of acute myocardial infarction by age (<65 and  ≥65 years) and gender: 1999-2007.
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A problem related to detecting the first attacks for cal-
culating incidence rates also could be construed as an-
other limitation of the current study. The national health 
insurance data has been computerized since 1995. There-
fore, when the first attacks were investigated, the cases 
occurring before 1995 were not considered. 
Third, the current study did not reflect changes in 
technologies for diagnosis. It was pointed out that the 
active introduction of the troponin test was a reason for 
the sharp increase in the attack and incidence rates in 
early 2000; however, it did not reflect those changes ac-
curately. These changes in technologies could increase 
attack or incidence rates and reduce fatality rates re-
gardless of changes in the actual risk of the population 
and of the quality of medical services.
30) 
Fourth, the severity of AMI was not adjusted. If mor-
tality caused by AMIs is decreased without a change in 
age structure or severity, such a change can be interpreted 
as a cause for improvement in the quality of medical ser-
vices.
30) 
In spite of these limitations, this study was meaning-
ful as the only study investigating a long-term disease 
incidence trend over 11 years with national health in-
surance claims data of the entire population, and the 
results are expected to be used as a major source of data 
for developing policies for the active prevention or man-
agement of AMIs. More research to determine more 
accurate causes for the changes in the disease scale and 
to evaluate outcomes of medical services are necessary. 
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